Search results
Results from the WOW.Com Content Network
The airways of asthma patients are "hypersensitive" to certain triggers, also known as stimuli (see below). (It is usually classified as type I hypersensitivity .) [ 4 ] [ 5 ] In response to exposure to these triggers, the bronchi (large airways) contract into spasm (an "asthma attack").
Acute severe asthma, also known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators (inhalers) and corticosteroids. [2] Asthma is caused by multiple genes , some having protective effect, with each gene having its own tendency to be influenced by the environment although a ...
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.
For premium support please call: 800-290-4726 more ways to reach us
Pulmonary drug delivery is a route of administration in which patients use an inhaler to inhale their medications and drugs are absorbed into the bloodstream via the lung mucous membrane. This technique is most commonly used in the treatment of lung diseases, for example, asthma and chronic obstructive pulmonary disease (COPD) .
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
Price stops 1 in 6 US adults with asthma from taking their life-saving medications as prescribed. Julia Musto. December 9, 2024 at 7:27 PM. The cost of medication to treat asthma, ... patients may ...
Occupational asthma – an estimated 2% to 5% of all asthma episodes may be caused by exposure to a specific sensitizing agent in the workplace. Nocturnal asthma is a characteristic problem in poorly controlled asthma and is reported by more than two-thirds of sub-optimally treated patients.